lily glp 1 Eli Lilly's Next-Generation GLP-1R Agonist Naperiglipron—Structure Revealed Eli Lilly Shows Why the

Metformin with GLP-RA Reported Better Tolerance A large-scale pharmacovigilance analysis of over 48,000 adverse event reports found that GLP-1RA and metformin combination therapy demonstrated a superior safety profile compared to either agent alone

These medications can be highly effective for weight loss and metabolic health, but they also come with side effects, high costs, and the need for lifestyle changes to maintain results

However, both can cause gastrointestinal side effects and affect weight, requiring careful monitoring when used together

Furthermore, the active ingredient in Wegovy has been approved for reducing the risk of major adverse cardiovascular events in adults with existing heart disease, adding an extra layer of benefit for certain patients

What this means for Washington State Medicare beneficiaries in 2026: For a full overview of how Medicare Parts A, B, C, and D work together in Washington, see our guide: Medicare Parts A, B, C & D in Washington State Explained

Some need longer medical supervision than others